Related references
Note: Only part of the references are listed.Ebola Virus Imported from Guinea to Senegal, 2014
Daye Ka et al.
EMERGING INFECTIOUS DISEASES (2017)
Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection
Stuart David Dowall et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
New Directions for Half-Life Extension of Protein Therapeutics: The Rise of Antibody Fc Domains and Fragments
Lili Wang et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2016)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti et al.
SCIENCE (2016)
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice
Devin Sok et al.
SCIENCE (2016)
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
John Misasi et al.
SCIENCE (2016)
Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
Davide Corti et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Development of therapeutics for treatment of Ebola virus infection
Haoyang Li et al.
MICROBES AND INFECTION (2015)
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Kristen E. Pascal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
Tianlei Ying et al.
NATURE COMMUNICATIONS (2015)
Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail
Jeffrey R. Kugelman et al.
CELL REPORTS (2015)
An update on Middle East respiratory syndrome: 2 years later
Jaffar A. Al-Tawfiq et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2015)
Evolutionary history of Ebola virus
Y. H. Li et al.
EPIDEMIOLOGY AND INFECTION (2014)
Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
Tianlei Ying et al.
JOURNAL OF VIROLOGY (2014)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Clinical Care of Two Patients with Ebola Virus Disease in the United States
G. Marshall Lyon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
Xian-Chun Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
Andrew J. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
Yang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
VIROLOGY Receptor for new coronavirus found
Declan Butler
NATURE (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
Gene Garrard Olinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
Sander van Boheemen et al.
MBIO (2012)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
Jody D. Berry et al.
NEW BIOTECHNOLOGY (2011)
Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity
Chantelle L. Hood et al.
JOURNAL OF VIROLOGY (2010)
Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine
Jason S. Richardson et al.
PLOS ONE (2009)
Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
Xiangguo Qiu et al.
PLOS ONE (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Jeffrey E. Lee et al.
NATURE (2008)
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhongyu Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of Ebola virus GP DNA vaccines
William Dowling et al.
JOURNAL OF VIROLOGY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
SM Jones et al.
NATURE MEDICINE (2005)
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants
JH Sui et al.
JOURNAL OF VIROLOGY (2005)
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
ZY Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
JH Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
Severe acute respiratory syndrome
JSM Peiris et al.
NATURE MEDICINE (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
T Kuiken et al.
LANCET (2003)
Identification of severe acute respiratory syndrome in Canada
SM Poutanen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Aetiology -: Koch's postulates fulfilled for SARS virus
RAM Fouchier et al.
NATURE (2003)
Coronavirus as a possible cause of severe acute respiratory syndrome
JSM Peiris et al.
LANCET (2003)
A method for the generation of combinatorial antibody libraries using pIX phage display
CS Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein
Y Huang et al.
MOLECULAR CELL (2002)
CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes
MD Gorrell et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Coronavirus spike proteins in viral entry and pathogenesis
TM Gallagher et al.
VIROLOGY (2001)
Share Paper
